A two-day workshop on the "science behind pharmaceutical stability" was held in conjunction with the Annual Meeting of American Association of Pharmaceutical Scientists (AAPS) on Oct. 21-22, 2011 in Washington, DC.
Robert H. Seevers
Advertisement
Robert H. Seevers, PhD, is with Eli Lilly and Company.
Articles by Robert H. Seevers
A two-day workshop on the "science behind pharmaceutical stability" was held in conjunction with the Annual Meeting of American Association of Pharmaceutical Scientists (AAPS) on Oct. 21-22, 2011 in Washington, DC.
Advertisement
Latest Updated Articles
- AAPS Workshop Summary
Published: November 2nd 2012 | Updated:
- Pharmaceutical Stability: Scientific and Regulatory Considerations for Global Drug Development and Commercialization
Published: November 3rd 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Audits, Inspections, and CDMOs
3
Ready or Not: Biopharma Alignment for CNPV’s Rapid Review
4
Comparator Selection & Supply: Best Practices for Clinical Success
5
